GlassScriptPhysician profile
Bailey Kathleen Caughlan
NPI 1164186425
$393.34
in general payments reported to CMS, 2019-2025
14 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.12 · 2023: $58.23 · 2024: $109 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.22 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $65.85 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $53.99 | 2022-2024 | Breztri, Airsupra |
| Novo Nordisk INC | $49.98 | 2023-2025 | Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $49.36 | 2022-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.35 | 2022-2023 | Trulance, Xifaxan |
| Inspire Medical Systems, INC. | $20.10 | 2024 | Inspire |
| Pfizer INC. | $19.95 | 2025 | |
| Cranial Technologies, INC | $19.27 | 2024 | Doc Band |
| Exact Sciences Corporation | $18.07 | 2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $15.37 | 2025 | Fanapt, Hetlioz |
| Corcept Therapeutics | $13.86 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $13.37 | 2024 | |
| Hologic Sales and Service, LLC | $12.88 | 2022 | |
| Merck Sharp & Dohme LLC | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Caughlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.